Qianlie Beixi capsule for unliquefiable semen: a clinical study of 180 cases
Zhang, X.-D.; Jin, B.-F.; Zhou, Y.-C.; Shang, X.-J.; Zhang, H.-J.; Liu, J.-G.; Li, X.-R.; Li, T.-F.; Huang, Y.-F.; Xu, F.-S.
Zhonghua Nan Ke Xue 15(7): 665-668
2009
ISSN/ISBN: 1009-3591 PMID: 19694385 Document Number: 636926
To investigate the efficacy and possible action mechanism of Qianlie Beixi Capsule in the treatment of unliquefiable semen. A total of 240 patients with unliquefiable semen were randomly divided into a treatment group (n = 180), treated with Qianlie Beixi Capsule, and a control group (n = 60), given compound tablets of zinc and protein. The treatment lasted two courses of 45 days each, and the seminal changes were observed and recorded. Of the patients in the treatment group, 144 were cured, 12 responded and 24 failed to respond to the medication after the first course; and 158 were cured, 7 responded and 15 failed to after the second course, with the effectiveness rate of 91.67%. Meanwhile, sperm motility was obviously improved, with statistically significant difference from that of the controls (P < 0.01). Qianlie Beixi Capsule is effective for unliquefiable semen by improving the function of the prostate and shortening the time of seminal liquefaction.